Next Article in Journal
SARS-CoV-2 Infection-Blocking Immunity Post Natural Infection: The Role of Vitamin D
Next Article in Special Issue
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
Previous Article in Journal
Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy during SARS-CoV-2 Infection and Vaccination
Previous Article in Special Issue
Case Report of Serum Sickness-like Reaction following the First Dose of the Chimpanzee Adenovirus-Vectored AstraZeneca COVID-19 Vaccine, ChAdOx1
 
 
Article

Article Versions Notes

Vaccines 2023, 11(2), 476; https://doi.org/10.3390/vaccines11020476
Action Date Notes Link
article xml file uploaded 17 February 2023 14:50 CET Original file -
article xml uploaded. 17 February 2023 14:50 CET Update https://www.mdpi.com/2076-393X/11/2/476/xml
article pdf uploaded. 17 February 2023 14:50 CET Version of Record https://www.mdpi.com/2076-393X/11/2/476/pdf
article html file updated 17 February 2023 14:52 CET Original file -
article html file updated 9 March 2023 20:51 CET Update https://www.mdpi.com/2076-393X/11/2/476/html
Back to TopTop